OLMA
NASDAQ · Biotechnology
Olema Pharmaceuticals Inc
$9.82
-0.08 (-0.81%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+71.2% upside
Low Target
$15.48
Average Target
$16.81
High Target
$21.94
Current Price
$9.82
Current
$9.82
$9.82
Target
$16.81
$16.81
$15.48
$16.81 avg
$21.94
Scenario Analysis
Bear Case
$15.48
57.6%
Low target
Base Case
$16.81
+71.2%
Avg target
Bull Case
$21.94
+123.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$36.26
-72.9% from high
52-Week Low
$6.65
+47.7% from low
Target vs 52W High
$16.81
-53.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |